InvestorsObserver
×
News Home

Can BioNTech SE - ADR (BNTX) Stock Rise to the Top of Healthcare Sector Thursday?

Thursday, January 26, 2023 11:20 AM | InvestorsObserver Analysts

Mentioned in this article

Can BioNTech SE - ADR (BNTX) Stock Rise to the Top of Healthcare Sector Thursday?

BioNTech SE - ADR (BNTX) is near the top in its sector according to InvestorsObserver. BNTX gets an overall rating of 73. That means it scores higher than 73% of stocks. BioNTech SE - ADR gets a 76 rank in the Healthcare sector. Healthcare is number 4 out of 11 sectors.

Overall Score - 73
BNTX has an Overall Score of 73. Find out what this means to you and get the rest of the rankings on BNTX!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 73 means the stock is more attractive than 73 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With BioNTech SE - ADR Stock Today?

BioNTech SE - ADR (BNTX) stock is lower by -1.05% while the S&P 500 is up 0.04% as of 11:07 AM on Thursday, Jan 26. BNTX has fallen -$1.50 from the previous closing price of $142.73 on volume of 150,195 shares. Over the past year the S&P 500 has fallen -7.63% while BNTX has fallen -12.12%. BNTX earned $44.54 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 3.17. Click Here to get the full Stock Report for BioNTech SE - ADR stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App